Canada’s Federal Court of Appeal Limits Damages Available to Delayed Generics

June 08, 2009

Tags:

Food and Drug Regulatory Intellectual Property Intellectual Property Litigation Patents Pharmaceuticals

Related Expertise

Related Insights

Déjà vu: Another delay in implementation of Canada’s PMPRB Regulations
Get your daily dose! Regulatory framework for supplemented foods and updated labelling for natural health products coming to Canada
Orphan Drugs in Canada: A “One Size Fits All” Regulatory Regime
Proof of vaccination: privacy considerations for businesses
Patents to Salts of Medicinal Ingredients to Become Listable on “Canada’s Orange Book”

Back